Patients with asthma diagnosed asthma,
Conditions
Interventions
The trial evaluates an intervention involving pharmacists to deliver one-
one education session about: (1) asthma medication that has been used (2) how to use asthma medication devices correctly (3) asthma symptoms and how to prevent the asthma exacerbations and (4) how to
how to recognize worsening asthma,
what to do when symptoms are getting worse and what to do in the event of an acute attack,
including a first aid plan,Participants allocated to the control group received the usual medical care provided by the Department of Pulmonology and/or their healthcare professionals. This included th
it was apparent that their asthma control had deteriorated since prior assessment (for example
using their reliever two or more times a week,
needing to increase their preventer dose),
the participant and her health professionals will be notified with participant’s permission.
Experimental Other,No Intervention Other
Education session by pharmacist,Usual Care
Sponsors
Ministry of Technology and Higher Education of Indonesia
Ministry of Technology and Higher Education of Indonesia
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Eligibility for this trial included patients with asthma who had used any regular medications for asthma within the previous 12 months, aged 18 years or older and able to communicate in Indonesian.
Exclusion criteria
Exclusion criteria: Those who are not able or contra indicated to perform lung function with spirometer will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in asthma control baseline and every 1, 2 and 3 months Asthma Control Questionnaire (ACQ) | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in Asthma Quality of Life baseline and every 1, 2 and 3 months Asthma Quality of Life Questionnaire (AQLQ) ,Forced Expiratory Volume in 1 second (FEV1) baseline and every 1, 2 and 3 months Spirometer,asthma-related health visits, days off work/study, and oral corticosteroid use baseline and at 3 months Questionnaire and patient medical records,Adherence score baseline and every 1, 2 and 3 months Adherence to Refills and Medications Scales (ARMS) questionnaire | — |
Countries
Indonesia
Contacts
Public ContactElida Zairina
Universitas Airlangga
Outcome results
None listed